Programmed Death-1: From gene to protein in autoimmune human myasthenia gravis

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 149-155

  Sakthivel, Priya ^a   Ramanujam, Ryan ^a   Wang, Xiong Biao ^a   Pirskanen, Ritva ^b   Lefvert, Ann Kari ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Monocytes; Myasthenia Gravis (MG); Programmed Death Ligand 1 (PD L1); Programmed Death 1 (PD 1); Single Nucleotide Polymorphism (SNP); T cells

Indexed keywords

CELL PROTEIN; PROGRAMMED DEATH 1 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYASTHENIA GRAVIS; NEUROIMMUNOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CHILD; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 37749017025     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.019     Document Type: Article

References (25)

1. Conti-Fine B.M., Milani M., and Kaminski H.J. Myasthenia gravis: past, present, and future. J. Clin. Invest. 116 (2006) 2843-2854
2. del Rio M.L., Penuelas-Rivas G., Dominguez-Perles R., Ramirez P., Parrilla P., and Rodriguez-Barbosa J.I. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation. Eur. J. Immunol. 35 (2005) 3545-3560
3. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., and Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192 (2000) 1027-1034
4. Gygi S.P., Rochon Y., Franza B.R., and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19 (1999) 1720-1730
5. Hatachi S., Iwai Y., Kawano S., Morinobu S., Kobayashi M., Koshiba M., Saura R., Kurosaka M., Honjo T., and Kumagai S. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J. Rheumatol. 30 (2003) 1410-1419
6. Hohlfeld R., Toyka K.V., Heininger K., Grosse-Wilde H., and Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 310 (1984) 244-246
7. Kakoulidou M., Ahlberg R., Yi Q., Giscombe R., Pirskanen R., and Lefvert A.K. The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis. J. Neuroimmunol. 148 (2004) 183-191
8. Kalb B., Matell G., Pirskanen R., and Lambe M. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden. Neuroepidemiology 21 (2002) 221-225
9. Kanai T., Totsuka T., Uraushihara K., Makita S., Nakamura T., Koganei K., Fukushima T., Akiba H., Yagita H., Okumura K., Machida U., Iwai H., Azuma M., Chen L., and Watanabe M. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171 (2003) 4156-4163
10. Kobayashi M., Kawano S., Hatachi S., Kurimoto C., Okazaki T., Iwai Y., Honjo T., Tanaka Y., Minato N., Komori T., Maeda S., and Kumagai S. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjogren's syndrome. J. Rheumatol. 32 (2005) 2156-2163
11. Kroner A., Mehling M., Hemmer B., Rieckmann P., Toyka K.V., Maurer M., and Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann. Neurol. 58 (2005) 50-57
12. Lee S.H., Lee Y.A., Woo D.H., Song R., Park E.K., Ryu M.H., Kim Y.H., Kim K.S., Hong S.J., Yoo M.C., and Yang H.I. Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res. Ther. 8 (2006) R163
13. Lin S.C., Yen J.H., Tsai J.J., Tsai W.C., Ou T.T., Liu H.W., and Chen C.J. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 770-775
14. Martin-Orozco N., Wang Y.H., Yagita H., and Dong C. Cutting edge: Programmed Death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens. J. Immunol. 177 (2006) 8291-8295
15. Nielsen C., Hansen D., Husby S., Jacobsen B.B., and Lillevang S.T. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62 (2003) 492-497
16. Nielsen C., Ohm-Laursen L., Barington T., Husby S., and Lillevang S.T. Alternative splice variants of the human PD-1 gene. Cell. Immunol. 235 (2005) 109-116
17. Nishimura H., Minato N., Nakano T., and Honjo T. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10 (1998) 1563-1572
18. Nishimura H., Nose M., Hiai H., Minato N., and Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 (1999) 141-151
19. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., and Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291 (2001) 319-322
20. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., Brookes A.J., Tentler D., Kristjansdottir H., Grondal G., Bolstad A.I., Svenungsson E., Lundberg I., Sturfelt G., Jonssen A., Truedsson L., Lima G., Alcocer-Varela J., Jonsson R., Gyllensten U.B., Harley J.B., Alarcon-Segovia D., Steinsson K., and Alarcon-Riquelme M.E. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32 (2002) 666-669
21. Prokunina L., Padyukov L., Bennet A., de Faire U., Wiman B., Prince J., Alfredsson L., Klareskog L., and Alarcon-Riquelme M. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum. 50 (2004) 1770-1773
22. Sharpe A.H., Wherry E.J., Ahmed R., and Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8 (2007) 239-245
23. Tsutsumi Y., Jie X., Ihara K., Nomura A., Kanemitsu S., Takada H., and Hara T. Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes. Diabet. Med. 23 (2006) 1145-1150
24. Wan B., Nie H., Liu A., Feng G., He D., Xu R., Zhang Q., Dong C., and Zhang J.Z. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 177 (2006) 8844-8850
25. Wang X.B., Kakoulidou M., Giscombe R., Qiu Q., Huang D., Pirskanen R., and Lefvert A.K. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J. Neuroimmunol. 130 (2002) 224-232